By elucidating the role of CDKN2A in glioblastoma cell behavior and its interaction with important signaling pathways, we aim to pave the way for the development of novel treatment strategies that could improve patient outcomes in this devastating disease. This evidence concerns the gene CDKN2A and glioblastoma.